These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 25989696

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Luo L, Zhang L, Cai B, Li H, Huang W, Jing Y, Zhu H, Zhao Y, Bo J, Wang Q, Han X, Yu L, Gao C.
    Ann Transplant; 2014 Jan 08; 19():6-12. PubMed ID: 24399278
    [Abstract] [Full Text] [Related]

  • 23. Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years.
    Vergote VKJ, Deroose CM, Fieuws S, Laleman W, Sprangers B, Uyttebroeck A, Van Cleemput J, Verhoef G, Vos R, Tousseyn T, Dierickx D.
    Transpl Int; 2022 Jan 08; 35():10707. PubMed ID: 36589262
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Jan 08; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 26. Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.
    Yang F, Li Y, Braylan R, Hunger SP, Yang LJ.
    Pediatr Blood Cancer; 2008 Feb 08; 50(2):415-8. PubMed ID: 17051534
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A.
    Clin Transplant; 2013 Feb 08; 27(4):E491-7. PubMed ID: 23781897
    [Abstract] [Full Text] [Related]

  • 28. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
    Yoon JH, Lee S, Kim HJ, Lee JW, Min WS, Chung BH, Yang CW, Kim YS, Kim JI, Moon IS, Oh EJ, Park GS, Cho SG.
    Transpl Int; 2014 Jul 08; 27(7):721-32. PubMed ID: 24684689
    [Abstract] [Full Text] [Related]

  • 29. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H, Taheri S.
    Ann Transplant; 2011 Jul 08; 16(1):109-16. PubMed ID: 21436784
    [Abstract] [Full Text] [Related]

  • 30. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, Caligiuri MA, Baiocchi RA.
    Transplantation; 2015 Jun 08; 99(6):1220-5. PubMed ID: 25427163
    [Abstract] [Full Text] [Related]

  • 31. Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
    Karuturi M, Shah N, Frank D, Fasan O, Reshef R, Ahya VN, Bromberg M, Faust T, Goral S, Schuster SJ, Stadtmauer EA, Tsai DE.
    Transpl Int; 2013 Jun 08; 26(6):616-22. PubMed ID: 23551167
    [Abstract] [Full Text] [Related]

  • 32. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.
    Clin Transplant; 2005 Jun 08; 19(3):327-34. PubMed ID: 15877793
    [Abstract] [Full Text] [Related]

  • 33. [A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation].
    Xu LP, Huang XJ, Liu DH, Chen YH, Shi HX, Chen DB.
    Zhonghua Nei Ke Za Zhi; 2007 Dec 08; 46(12):996-9. PubMed ID: 18478915
    [Abstract] [Full Text] [Related]

  • 34. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 08; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 35. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study.
    Lo RC, Chan SC, Chan KL, Chiang AK, Lo CM, Ng IO.
    J Clin Pathol; 2013 May 08; 66(5):392-8. PubMed ID: 23423516
    [Abstract] [Full Text] [Related]

  • 36. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients.
    Schober T, Framke T, Kreipe H, Schulz TF, Großhennig A, Hussein K, Baumann U, Pape L, Schubert S, Wingen AM, Jack T, Koch A, Klein C, Maecker-Kolhoff B.
    Transplantation; 2013 Jan 15; 95(1):240-6. PubMed ID: 23222898
    [Abstract] [Full Text] [Related]

  • 37. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M.
    Haematologica; 2006 Aug 15; 91(8):1059-67. PubMed ID: 16885046
    [Abstract] [Full Text] [Related]

  • 38. Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation.
    Subklewe M, Marquis R, Choquet S, Leblond V, Garnier JL, Hetzer R, Swinnen LJ, Oertel S, Papp-Vary M, Gonzalez-Barca E, Hepkema BG, Schoenemann C, May J, Pezzutto A, Riess H.
    Transplantation; 2006 Oct 27; 82(8):1093-100. PubMed ID: 17060859
    [Abstract] [Full Text] [Related]

  • 39. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ.
    Transpl Int; 2007 Mar 27; 20(3):207-18. PubMed ID: 17291214
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.